Key result
Cloning apolipoprotein(a) and developing transgenic mouse models establish critical platforms to investigate lipoprotein(a) atherogenicity.
Key points are not available for this paper at this time.
Answers are grounded in this paper and cite their sources.
Important advances have been made in the past year in our understanding of the genetics of lipoprotein (a) [Lp(a)]. The apolipoprotein (a) [APO(a)] gene has been cloned and mice have been engineered to express apo(a) and Lp(a). These developments have provided the tools to answer many fundamental questions concerning the genetics, metabolism, and atherogenicity of Lp(a).
No takes yet. Share an insight, caveat, or question.
Gaw et al. (1994) studied this question. Cloning of the apolipoprotein (a) gene and engineering of transgenic mice provide essential tools to investigate the genetics, metabolism, and atherogenicity of lipoprotein (a).
Synapse has enriched 10 related papers. Consider them for comparative context: